Schonfeld Strategic Advisors LLC - RECURSION PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 159 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$626,083
-49.7%
81,204
-30.6%
0.01%
-50.0%
Q3 2022$1,244,000
-11.3%
117,011
-32.0%
0.01%
-28.6%
Q2 2022$1,402,000
+115.7%
172,195
+89.6%
0.01%
+133.3%
Q1 2022$650,000–90,800–0.01%–
 Download
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Data Collective IV GP, LLC 5,941,120$45,806,03548.11%
Kinnevik AB (publ) 7,653,061$59,005,10033.28%
MV Management XI, L.L.C. 1,971,908$15,203,41126.45%
MIC Capital Management UK LLP 8,451,758$65,163,05712.86%
ArchPoint Investors 1,114,626$8,593,7664.07%
HARVARD MANAGEMENT CO INC 1,509,254$11,636,3481.44%
PLATINUM INVESTMENT MANAGEMENT LTD 2,710,339$20,896,7140.80%
Duquesne Family Office 1,385,950$10,685,6750.53%
ALLEN OPERATIONS LLC 217,657$1,678,1350.45%
Artal Group S.A. 960,204$7,4030.41%
View complete list of RECURSION PHARMACEUTICALS IN shareholders